This article acknowledges the historical importance of the work of Elisabeth Kübler-Ross and her five stages model. Because her name and this model appear in many textbooks, professional educational programs, and popular culture, should we incorporate these subjects in responsible ways in our current teaching and practice? The answer proposed here is that we should incorporate these subjects, but only if (a) we focus on her recommendations on behalf of active listening and learning from persons diagnosed with a terminal illness, (b) we limit ourselves to her descriptions of the individual reactions and responses experienced by her interviewees, (c) we acknowledge criticisms of the five stages model as a framework for understanding coping with life-threatening illness and dying, (d) we draw instead on alternative theories of coping with dying, and (e) we recognize dangers in applying this model to issues involving loss, grief, and bereavement and do not do so.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0030222819865397 | DOI Listing |
World J Urol
January 2025
Department of Urology, Charité - Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Purpose: The objective of this study was to evaluate the perioperative outcomes and complications associated with the use of acetylsalicylic acid (ASA) in deceased donor kidney transplantation (KTX), with a particular focus on bleeding events.
Methods: We retrospectively analyzed 157 kidney transplant recipients (KTRs) who underwent KTX at Charité Berlin, Department for Urology, between February 2014 and December 2017. Patients were divided into two groups: patients with ASA in their preoperative medication (Group A, n = 59) and patients without ASA use (Group B, n = 98).
Mult Scler Relat Disord
December 2024
Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Marchioninistrasse 15 81377, Munich, Germany; Pettenkofer School of Public Health, Elisabeth-Winterhalter-Weg 6, 81377 Munich, Germany. Electronic address:
Background: The individual treatment response in people with relapsing-remitting multiple sclerosis (RRMS) remain unpredictable. In order to support medical decisions, we aimed to predict response to fingolimod compared to placebo, by developing and validating prognostic multivariable models.
Methods: We included two-year follow-up from intention-to-treat populations of two multi-country placebo-controlled randomized controlled trials (RCT) of daily fingolimod 0.
J Pediatr Surg
December 2024
Pediatric Surgery, Dipartimento di Medicina di Precisione e Rigenerativa a Area Jonica, Azienda Ospedaliera-Universitaria Consorziale Ospedale Pediatrico Giovanni XXIII, Bari, Italy.
Background And Aims: Image Defined Risk Factors (IDRFs) assess surgical risk in neuroblastoma (NB) and guide neoadjuvant therapy. Despite chemotherapy IDRFs may persist in 70 % of cases. Several studies have suggested that not all IDRFs hold equal significance and that the presence of an IDRF does not inherently signify unresectability.
View Article and Find Full Text PDFDent J (Basel)
December 2024
Department of Operative Dentistry, School of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece.
The aim was to evaluate the agreement between plaque detection with an intraoral scanner system (IOS) and a conventional clinical method and to evaluate the inter-rater reliability for scoring 3D models with and without a disclosing agent. : A total of 14 participants were recruited from the Department of Operative Dentistry, School of Dentistry, National and Kapodistrian University of Athens. Participants eligible for inclusion were adults with good general health and a minimum of 20 teeth.
View Article and Find Full Text PDFCureus
November 2024
Intensive Care Medicine, Elisabeth-Tweesteden Hospital, Tilburg, NLD.
Introduction Predatory journals are marked by inadequate editorial practices and peer review processes, diverging from established global standards in scientific publishing. This article, as a component of the ASGLOS Study, aims to explore the relationship between participant demographics and their experiences with targeted predatory business activities, including their approaches to managing daily predatory emails. Methods To collect the personal experiences of physicians' mailboxes on predatory publishing, a Google Form® survey was designed and disseminated from September 2021 to April 2022.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!